Helen Troy

1.2k total citations
20 papers, 918 citations indexed

About

Helen Troy is a scholar working on Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Helen Troy has authored 20 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cancer Research and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Helen Troy's work include Cancer, Hypoxia, and Metabolism (11 papers), Metabolomics and Mass Spectrometry Studies (6 papers) and Advanced MRI Techniques and Applications (5 papers). Helen Troy is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Metabolomics and Mass Spectrometry Studies (6 papers) and Advanced MRI Techniques and Applications (5 papers). Helen Troy collaborates with scholars based in United Kingdom, United States and Switzerland. Helen Troy's co-authors include Yuen‐Li Chung, John R. Griffiths, Manuel Mayr, Martin O. Leach, Qingbo Xu, Ursula Mayr, John R. Griffiths, Ian Judson, Marion Stubbs and Yanhua Hu and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Helen Troy

20 papers receiving 897 citations

Peers

Helen Troy

RNMI

SPECT

ONCOL

John Gounarides United States

Deguang Sun China

Xiaomeng Shen United States

Farshad Farshidfar Canada

David Meininger United States

Vasily A. Yakovlev United States

Rosemary Ronan United States

Jae Hyuck Choi South Korea

Christine Labeur Belgium

Agustı́n Rodrı́guez-González Spain

John Gounarides United States

Helen Troy

743 ×1.2

358 ×1.0

77 ×0.6

RNMI

104 ×0.8

SPECT

97 ×1.1

ONCOL

Citations per year, relative to Helen Troy Helen Troy (= 1×) peers John Gounarides

Countries citing papers authored by Helen Troy

Since Specialization

Citations

This map shows the geographic impact of Helen Troy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Troy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Troy more than expected).

Fields of papers citing papers by Helen Troy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Troy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Troy. The network helps show where Helen Troy may publish in the future.

Co-authorship network of co-authors of Helen Troy

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Troy. A scholar is included among the top collaborators of Helen Troy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Troy. Helen Troy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al-Saffar, Nada M.S., Helen Troy, L. Elizabeth Jackson, et al.. (2018). Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma. British Journal of Cancer. 119(9). 1118–1128. 14 indexed citations

Lin, Gigin, Helen Troy, Gabriela Andrejeva, et al.. (2016). Abstract B56: Treatment-induced autophagy increases amino acid uptake and switches glucose addiction to amino acid catabolism in cancer. Molecular Cancer Research. 14(1_Supplement). B56–B56. 1 indexed citations

Lin, Gigin, Deborah K. Hill, Gabriela Andrejeva, et al.. (2014). Dichloroacetate induces autophagy in colorectal cancer cells and tumours. British Journal of Cancer. 111(2). 375–385. 65 indexed citations

Beloueche‐Babari, Mounia, Helen Troy, Robert te Poele, et al.. (2011). Histone Deacetylase Inhibition Increases Levels of Choline Kinase α and Phosphocholine Facilitating Noninvasive Imaging in Human Cancers. Cancer Research. 72(4). 990–1000. 23 indexed citations

Troy, Helen, Yuen‐Li Chung, Paul M.J. McSheehy, et al.. (2011). Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. BMC Cancer. 11(1). 198–198. 24 indexed citations

Biswas, Swethajit, Helen Troy, Russell Leek, et al.. (2010). Effects of HIF-1 and HIF2 on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts. Journal of Oncology. 2010. 1–14. 70 indexed citations

Chung, Yuen‐Li, Helen Troy, Rebecca Kristeleit, et al.. (2008). Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of a Novel Histone Deacetylase Inhibitor, LAQ824, in Human Colon Carcinoma Cells and Xenografts. Neoplasia. 10(4). 303–313. 42 indexed citations

Evans, Andrew R., Helen Troy, Stephen M. Hewitt, et al.. (2007). Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemotherapy and Pharmacology. 61(3). 377–393. 70 indexed citations

Payne, Geoffrey S., Helen Troy, Sucheta Vaidya, et al.. (2006). Evaluation of ³¹P high‐resolution magic angle spinning of intact tissue samples. NMR in Biomedicine. 19(5). 593–598. 19 indexed citations

10.

Al-Saffar, Nada M.S., Helen Troy, Ana Ramı́rez de Molina, et al.. (2006). Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Choline Kinase Inhibitor MN58b in Human Carcinoma Models. Cancer Research. 66(1). 427–434. 109 indexed citations

11.

Mayr, Manuel, Yuen‐Li Chung, Ursula Mayr, et al.. (2005). Proteomic and Metabolomic Analyses of Atherosclerotic Vessels From Apolipoprotein E-Deficient Mice Reveal Alterations in Inflammation, Oxidative Stress, and Energy Metabolism. Arteriosclerosis Thrombosis and Vascular Biology. 25(10). 2135–2142. 148 indexed citations

12.

Troy, Helen, Yuen-Li Chung, Manuel Mayr, et al.. (2005). Metabolic profiling of hypoxia-inducible factor-1β-deficient and wild type Hepa-1 cells: effects of hypoxia measured by 1H magnetic resonance spectroscopy. Metabolomics. 1(4). 293–303. 10 indexed citations

13.

Kostourou, Vassiliki, Helen Troy, Joanne F. Murray, et al.. (2004). Overexpression of Dimethylarginine Dimethylaminohydrolase Enhances Tumor Hypoxia: An Insight into the Relationship of Hypoxia and Angiogenesis In Vivo. Neoplasia. 6(4). 401–411. 23 indexed citations

14.

Mayr, Manuel, Bernhard Metzler, Yuen‐Li Chung, et al.. (2004). Ischemic preconditioning exaggerates cardiac damage in PKC-δ null mice. American Journal of Physiology-Heart and Circulatory Physiology. 287(2). H946–H956. 95 indexed citations

15.

Chung, Yuen-Li, Helen Troy, Ian Judson, et al.. (2004). Noninvasive Measurements of Capecitabine Metabolism in Bladder Tumors Overexpressing Thymidine Phosphorylase by Fluorine-19 Magnetic Resonance Spectroscopy. Clinical Cancer Research. 10(11). 3863–3870. 13 indexed citations

16.

Mayr, Manuel, Yuen‐Li Chung, Ursula Mayr, et al.. (2004). Loss of PKC-δ alters cardiac metabolism. American Journal of Physiology-Heart and Circulatory Physiology. 287(2). H937–H945. 66 indexed citations

17.

Chung, Yuen‐Li, Helen Troy, Ian Judson, et al.. (2003). Pharmacokinetic measurements of a 5FU pro-drug, capecitabine, in bladder tumours over-expressing thymidine phosphorylase. Clinical Cancer Research. 9. 2 indexed citations

18.

McSheehy, Paul M.J., Helen Troy, Lloyd R. Kèlland, et al.. (2003). Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokinetics. European Journal of Cancer. 39(4). 532–540. 27 indexed citations

19.

Griffiths, John R., Paul M.J. McSheehy, Simon P. Robinson, et al.. (2002). Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathway.. PubMed. 62(3). 688–95. 87 indexed citations

20.

Argentieri, Thomas M., et al.. (1993). Electrophysiologic Activity and Antiarrhythmic Efficacy of CK-3579, a New Class III Antiarrhythmic Agent With β-Adrenergic Blocking Properties. Journal of Cardiovascular Pharmacology. 21(4). 647–655. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact